SCHEMBL7129857

SCHEMBL7129857

Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)no1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
HPGD P15428 4/20 0.59
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
GAA P10253 1/20 0.58
ALOX12 P18054 1/20 0.58
PPIA P62937 2/20 0.57
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPK1 P28482 1/20 0.56
PPARG P37231 1/20 0.56
PPARA Q07869 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
TSHR P16473 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
ALDH1A1 P00352 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048268 0.84 NPC1 (0.82) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL7129854 0.84 RORC (0.59) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL7118614 0.84 KMT2A (0.62) HPGDMEN1KMT2AGAACYP3A4
SCHEMBL7132305 0.84 KMT2A (0.62) HPGDMEN1KMT2AGAACYP3A4
SCHEMBL7132435 0.84 LMNA (0.64) MEN1KMT2APOLBCYP3A4ALOX15
SCHEMBL7126998 0.82 SMN1; SMN2 (0.58) MEN1KMT2APOLBCYP3A4ALOX15
SCHEMBL7127037 0.82 KMT2A (0.79) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL7129479 0.81 KMT2A (0.58) HPGDMEN1KMT2AGAACYP3A4
SCHEMBL7128804 0.81 MEN1 (0.74) HPGDMEN1KMT2ACYP3A4ALOX15
SCHEMBL7129852 0.80 TP53 (0.69) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD NPC1 1152/4885RAB9A 1179/4885HPGD 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.